Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kakizaki S et al. – CAR and PXR have a protective effect on cholestasis by activating both detoxification enzymes and transporters. As a result, novel compounds targeting CAR and PXR with specific effects and fewer side effects will therefore be useful for the treatment of cholestatic liver diseases. This article will review the current knowledge on xenobiotic–sensing nuclear receptors CAR and PXR, while also discussing their potential role in the treatment of cholestatic liver diseases.

Related Articles

Simplifying hepatic venous outflow reconstruction in sequential living donor liver transplantation
Liver Transplantation, 10/30/09    Relevance Score: 95%

Liver Regeneration in 120 Consecutive Living-Related Liver Donors
Transplantation Proceedings, 11/05/09    Relevance Score: 94%

A knowledge-based technique for liver segmentation in CT data
Computerized Medical Imaging and Graphics, 10/27/09    Relevance Score: 93%

Statin therapy initiated in a man with hepatitis C and elevated cholesterol
The Clinical Advisor, 10/07/09    Relevance Score: 93%

Recognizing and treating cutaneous signs of liver disease
Cleveland Clinic Journal of Medicine, 10/05/09    Relevance Score: 93%

Today in Stomach/GI...keeping you current

Proton Pump Inhibitors and Pain
Pain Physician, 11/25/09

Clinical Features of Gastroduodenal Ulcer in Japanese Patients Taking Low-Dose Aspirin
Digestive Diseases and Sciences, 11/25/09

Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis
Cephalon, 11/24/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address